Skip to main content
Figure 3 | BMC Immunology

Figure 3

From: Early changes of the kinetics of monocyte trem-1 reflect final outcome in human sepsis

Figure 3

Study primary endpoint: impact of TREM-1 expression on final outcome A) Survival analysis comparing patients with decrease of TREM-1 expression from day 1 to day 3 (n = 20) and patients with increase of TREM-1 expression from day 1 to day 3 (n = 18); B) Respective comparisons of the change of the expression of TREM-1 on circulating monocytes are provided; C) Comparison of the change of TREM-1 expression on circulating monocytes between day 3 and day 1 between survivors (n = 59) and non-survivors (n = 16). P values of comparisons are provided.

Back to article page